Forte Biosciences, Inc. (FBRX)
76.99
0.00 (0.00%)
USD |
NASDAQ |
Oct 16, 16:00
Forte Biosciences Net Income (TTM) : -87.94M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -87.94M |
| March 31, 2026 | -75.86M |
| December 31, 2025 | -69.38M |
| September 30, 2025 | -51.74M |
| June 30, 2025 | -42.45M |
| March 31, 2025 | -43.71M |
| December 31, 2024 | -35.48M |
| September 30, 2024 | -34.20M |
| June 30, 2024 | -35.76M |
| March 31, 2024 | -32.14M |
| December 31, 2023 | -31.48M |
| September 30, 2023 | -30.48M |
| June 30, 2023 | -23.93M |
| March 31, 2023 | -18.06M |
| December 31, 2022 | -13.88M |
| September 30, 2022 | -12.34M |
| June 30, 2022 | -16.69M |
| March 31, 2022 | -19.47M |
| December 31, 2021 | -21.71M |
| Date | Value |
|---|---|
| September 30, 2021 | -22.94M |
| June 30, 2021 | -20.29M |
| March 31, 2021 | -49.24M |
| December 31, 2020 | -46.49M |
| September 30, 2020 | -43.48M |
| June 30, 2020 | -39.06M |
| March 31, 2020 | -4.934M |
| December 31, 2019 | -19.97M |
| September 30, 2019 | -38.01M |
| June 30, 2019 | -37.70M |
| March 31, 2019 | -53.16M |
| December 31, 2018 | -48.96M |
| September 30, 2018 | -40.19M |
| June 30, 2018 | -49.76M |
| March 31, 2018 | -42.74M |
| December 31, 2017 | -38.93M |
| September 30, 2017 | -36.13M |
| June 30, 2017 | -34.19M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| argenx SE | 1.714B |
| ACADIA Pharmaceuticals, Inc. | 380.48M |
| Alnylam Pharmaceuticals, Inc. | 807.99M |
| Anika Therapeutics, Inc. | -3.121M |
| Savara, Inc. | -139.31M |